Ephedrine Sulfate — 50MG, Injection, carton of 25 × 1 mL vials

Ephedrine Sulfate — 50MG, Injection, carton of 25 × 1 mL vials

Ephedrine Sulfate is a injection for intravenous use. Ephedrine Sulfate Injection, USP is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. Ephedrine Sulfate Injection, USP is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. ( 1 )

• Active ingredient or product type: EPHEDRINE SULFATE
• Strength/concentration: 50MG
• Dosage form and route: Injection, Intravenous
• Exact package presentation: carton of 25 × 1 mL vials
• NDC/item number: 0641-6238-25
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store Ephedrine Sulfate Injection, USP, 50 mg/mL, at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in carton until time of use. Discard unused portion.
• Status: Rx only

Important safety information: Pressor Effects with Concomitant Use with Oxytocic Drugs : Pressor effect of sympathomimetic pressor amines is potentiated ( 5.1 ) Tachyphylaxis and Tolerance : Repeated administration of ephedrine may cause tachyphylaxis ( 5.2 ) 5.1 Pressor Effect with Concomitant Oxytocic Drugs Serious postpartum hypertension has been described in patients who received both a vasopressor (i.e., methoxamine, phenylephrine, ephedrine) and an oxytocic (i.e., methylergonovine, ergonovine) [see Drug Interactions (7

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.